$XMTR

Miln James sold $145K of XMTR

Miln James (Chief Financial Officer) sold 1,500 shares of Xometry, Inc. (XMTR) at an average of $96.90 ($94.44–$99.56, $0.15M total) across 6 trades on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Miln James
Published Jun 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
high confidence
Mentioned
$XMTR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

The newest disclosed fact is the CFO’s open-market sale details (shares, price range, total value) executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 plan and modest disclosed value relative to typical market moves suggest limited trading edge by itself.

03

What to watch

The filing does not indicate net selling pressure beyond this scheduled tranche, and it provides no performance or guidance context.

Relevance 3/10Novelty 3/10Timing: filed June 3, covering open-market sale on June 1

Background

The article is an SEC Form 4 insider transaction disclosure for Xometry, Inc. (XMTR).

Company-level read

Ticker impact

$XMTRNeutralHigh confidence
Context

Xometry CFO Miln James sold about 1,500 shares in open-market transactions under a 10b5-1 plan, totaling $145,344.92.

Expected impact

Likely minimal impact; any reaction should be small and short-lived unless paired with other company-specific news.

Evidence & confidence

Form 4 insider sales are common, and the filing explicitly states a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

No clear sector read-through from a single CFO 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, but the 10b5-1 structure makes that inference weaker.

Key entities

  • Xometry, Inc.

    Company whose CFO insider sale is disclosed via Form 4.

  • Miln James

    Chief Financial Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.